Lunai Bioworks (LNAI) Earnings Analysis
Lunai Bioworks (LNAI) has no confirmed upcoming earnings date. Trailing P/E -0.04.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does LNAI next report earnings?
No confirmed upcoming earnings date is currently scheduled for LNAI. This page updates as the calendar is published.
LNAI earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | -0.8 USD | n/a | n/a | n/a |
| 2026-02-17 | -0.08 USD | n/a | n/a | n/a |
| 2025-11-14 | 0.13 USD | n/a | n/a | n/a |
| 2025-05-15 | 0.0117 USD | n/a | n/a | n/a |
LNAI valuation and analyst view
| Trailing P/E | -0.04 |
|---|---|
| Trailing EPS | -41.06041 USD |
| Price / book | -0.85 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Lunai Bioworks (LNAI)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for LNAI. This page updates as the calendar is published.
Did LNAI beat earnings last quarter?
Consensus estimate data was not available for LNAI's 2026-05-15 report.
What is LNAI's current P/E ratio and EPS?
LNAI trades at a trailing P/E of -0.04 on trailing EPS of -41.06041017516064 USD.
What do analysts rate LNAI?
LNAI has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.